BIOMERIEUX (EPA:BIM) | WebDisclosure

Basculer en Français

9480	Companies
185559	Keywords
117951	Articles
99390	Press releases

Home
Companies
BIOMERIEUX

REGULATED PRESS RELEASE

published on 05/28/2024 at 18:01, 1 year 6 months ago

bioMérieux obtient l'agrément 510(k) de la FDA pour le test innovant VIDAS® TBI (GFAP, UCH-L1), visant à améliorer l’évaluation des patients victimes d'un traumatisme crânien léger
bioMérieux obtient l'agrément 510(k) de la FDA pour le test VIDAS® TBI (GFAP, UCH-L1) améliorant l'évaluation des traumatismes crâniens légers

FDA BioMérieux Agrément 510(k) VIDAS TBI Traumatisme Crânien Léger
BRIEF

published on 05/23/2024 at 13:07, 1 year 6 months ago

Le Malawi s'attaque à l'antibiorésistance grâce à une collaboration multisectorielle

BioMérieux Antibiorésistance Santé Publique Malawi Pfizer
BRIEF

published on 05/23/2024 at 13:07, 1 year 6 months ago

Malawi Ministry of Health, bioMérieux, and Pfizer Form Country's First Multisectoral Collaboration to Address Antimicrobial Resistance

BioMérieux Antimicrobial Resistance Public Health Pfizer Malawi Health
REGULATED PRESS RELEASE

published on 05/23/2024 at 13:02, 1 year 6 months ago

Le Ministère de la Santé du Malawi, bioMérieux et Pfizer créent la première collaboration multisectorielle dans ce pays pour lutter contre l'antibiorésistance
Le Ministère de la Santé du Malawi, bioMérieux et Pfizer lancent une collaboration contre l'antibiorésistance avec des initiatives multisectorielles innovantes. Objectif : renforcer l'action publique et l'usage approprié des antibiotiques

BioMérieux Antibiorésistance Malawi Pfizer Ministère De La Santé
REGULATED PRESS RELEASE

published on 05/23/2024 at 13:02, 1 year 6 months ago

Malawi Ministry of Health, bioMérieux, and Pfizer Form Country’s First Multisectoral Collaboration to Help Address Antimicrobial Resistance
Malawi Ministry of Health, bioMérieux, and Pfizer collaborate to address antimicrobial resistance in Malawi through infection prevention, control, diagnostics, and surveillance. The initiative aims to combat AMR, a global health threat

BioMérieux Antimicrobial Resistance Collaboration Pfizer Malawi Ministry Of Health
BRIEF

published on 05/06/2024 at 17:23, 1 year 6 months ago

Mise à jour financière de bioMérieux : Aperçu du capital social et des droits de vote en avril 2024

Droits De Vote Capital Social BioMérieux Actions Diagnostic In Vitro
BRIEF

published on 05/06/2024 at 17:23, 1 year 6 months ago

BioMérieux financial update: Overview of share capital and voting rights in April 2024

Share Capital Voting Rights BioMérieux Actions In Vitro Diagnostics
REGULATED PRESS RELEASE

published on 05/06/2024 at 17:18, 1 year 6 months ago

Avril 2024 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Communiqué de presse mensuel de bioMérieux concernant le nombre total de droits de vote et d'actions, conformément aux réglementations financières en vigueur

Autorité Des Marchés Financiers BioMérieux Nombre De Droits De Vote Règlement Général Informations Mensuelles
BRIEF

published on 04/09/2024 at 07:20, 1 year 7 months ago

BioMérieux Outlines Ambitious Five-Year Strategic Growth Plan

Corporate Social Responsibility BioMérieux In Vitro Diagnostics Sustainable Growth GO•28 Strategic Plan
BRIEF

published on 04/09/2024 at 07:20, 1 year 7 months ago

BioMérieux dévoile GO•28, son plan stratégique quinquennal

BioMérieux Diagnostic In Vitro Croissance Organique RSE GO•28

Accesswire

Published on 12/05/2025 at 21:45, 1 hour 5 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 1 hour 20 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 1 hour 30 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 1 hour 50 minutes ago

The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 2 hours 25 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 34 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 38 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 3 hours 52 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 4 hours 23 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 4 hours 34 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 17:18, 5 hours 32 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 5 hours 32 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 7 hours 39 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 7 hours 39 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 8 hours 51 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE